{
    "Case ID": "070774",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement"
    ],
    "Legal_Issue": [
        "Award of costs following unsuccessful patent infringement claim"
    ],
    "Governing_Law": [
        "Federal Courts Rules, Rule 400(1)"
    ],
    "Procedural_Stage": [
        "Post-trial, cost determination phase"
    ],
    "Evidence_Assessment": [
        "Complexity of case, pre-trial work, settlement offers"
    ],
    "Decision_Outcome": [
        "Novopharm entitled to costs with adjustments"
    ],
    "Burden_of_Proof": [
        "On claimants (Sanofi and Schering) to justify claims"
    ],
    "Credibility_Factor": [
        "Seriousness of Novopharm's settlement offers"
    ],
    "Legal_Rule": [
        "Court has discretionary power over cost allocation under Rule 400(1)"
    ],
    "Standard_of_Review": [
        "Discretionary standard applied by the court"
    ],
    "Procedural_Issue": [
        "Allocation of costs after invalidated claims"
    ],
    "Grounds_for_Claim": [
        "Infringement of Canadian Patent No. 1,341,206 related to ramipril"
    ],
    "Outcome_on_Merits": [
        "Claims by Sanofi and Schering were invalidated"
    ],
    "Decision_Maker": [
        "Judge Snider"
    ],
    "Judicial_Review_Outcome": [
        "Costs awarded to Novopharm with adjustments"
    ],
    "Review_Standard": [
        "Discretionary review based on fairness and conduct"
    ],
    "Procedural_Fairness_Assessment": [
        "Consideration of settlement behavior and procedural efficiency"
    ],
    "Key_Evidence_Considered": [
        "Settlement offers, trial complexity, non-essential expenses"
    ],
    "Legal_Framework": [
        "Federal Courts Rules, Canadian patent law"
    ],
    "Applicant_Challenge": [
        "Sanofi and Schering's patent enforcement efforts"
    ],
    "Court_Result": [
        "Adjusted cost award in favor of Novopharm"
    ],
    "Legal_Rule_Source": [
        "Rule 400(1) of the Federal Courts Rules"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Denial of recovery for non-essential expenses, counterarguments on costs"
    ],
    "Evidence_Type": [
        "Documentary evidence, settlement correspondence, trial records"
    ],
    "Remedy_Requested": [
        "Costs following dismissal of patent claims"
    ],
    "Outcome": [
        "Costs awarded at upper end of Column IV, +30% for settlement, -20% for inefficiencies"
    ],
    "Decision_Authority": [
        "Federal Court, Judge Snider"
    ],
    "Remedy_Sought": [
        "Recovery of legal costs incurred in defense"
    ],
    "Resolution_Mechanism": [
        "Judicial determination post-trial"
    ],
    "Legal_Provision": [
        "Rule 400(1), Federal Courts Rules"
    ],
    "Authority": [
        "Federal Court of Canada"
    ],
    "Claimant_Status": [
        "Sanofi and Schering as patent holders and plaintiffs"
    ],
    "Legal_Provision_Cited": [
        "Rule 400(1)"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Invalidity of patent claims"
    ],
    "Applicable_Process": [
        "Trial and post-judgment submissions on costs"
    ],
    "Outcome_of_Review": [
        "Partial cost recovery granted with adjustments"
    ],
    "Pending_Relief_or_Application": [
        "Application for costs after judgment"
    ],
    "Jurisdiction": [
        "Federal Court of Canada"
    ],
    "Governing_Rule": [
        "Rule 400(1) of the Federal Courts Rules"
    ]
}